These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2916412)

  • 1. Noninvasive assessment of diastolic and systolic properties of ibopamine in patients with congestive heart failure.
    Stoddard MF; Chaitman BR; Byers SL; Mrosek D; Labovitz AJ
    Am Heart J; 1989 Feb; 117(2):395-402. PubMed ID: 2916412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the acute effects of ibopamine with those of dopamine on the echocardiographic parameters of systolic function of the heart in congestive cardiac failure].
    Sannia L; Dore L; Castellaccio M; Scorcu G; Ibba GV
    Minerva Cardioangiol; 1986 Nov; 34(11):685-9. PubMed ID: 3808337
    [No Abstract]   [Full Text] [Related]  

  • 3. Noninvasive evaluation of the effects of oral ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure.
    Dei Cas L; Manca C; Bernardini B; Vasini G; Visioli O
    J Cardiovasc Pharmacol; 1982; 4(3):436-40. PubMed ID: 6177940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine congener, ibopamine, in congestive heart failure.
    Ren JH; Unverferth DV; Leier CV
    J Cardiovasc Pharmacol; 1984; 6(5):748-55. PubMed ID: 6209476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Echocardiographic and polygraphic study of acute/effects of Ibopamine on cardiac performance].
    Ladelli L; Pezzano A; Sala G; Mangiavacchi M; Cadel A; Brusoni B
    G Ital Cardiol; 1983 Oct; 13(10):239-48. PubMed ID: 6667808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of left ventricular diastolic function using Doppler echocardiography].
    Vlahović A; Popović AD
    Med Pregl; 1999; 52(1-2):13-8. PubMed ID: 10352498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular filling pattern in congestive heart failure patients with normal sinus rhythm--a decreased ratio of peak mitral flow velocity in atrial systole relative to that in early diastole may reflect markedly increased left ventricular end-diastolic pressure.
    Iga K; Hori K; Matsumura T; Tomonaga G; Gen H; Tamamura T
    Jpn Circ J; 1990 May; 54(5):473-7. PubMed ID: 2232110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction.
    Morris DA; Boldt LH; Eichstädt H; Ozcelik C; Haverkamp W
    Circ Heart Fail; 2012 Sep; 5(5):610-20. PubMed ID: 22874137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atrial filling fraction predicts left ventricular systolic function after myocardial infarction: pre-discharge echocardiographic evaluation].
    Galderisi M; Fakher A; Petrocelli A; Alfieri A; Garofalo M; de Divitiis O
    Cardiologia; 1995 Oct; 40(10):763-8. PubMed ID: 8819737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diastolic function of the left ventricle and congestive heart failure with normal systolic function].
    Rusconi C
    Ital Heart J Suppl; 2000 Oct; 1(10):1273-80. PubMed ID: 11068708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study.
    Partanen J; Nieminen MS; Lehto H
    Clin Cardiol; 1988 Jan; 11(1):15-22. PubMed ID: 3349658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group.
    Cavalli A; Riva E; Schleman M; Abbondati G; Fuccella LM
    Int J Cardiol; 1989 Mar; 22(3):381-7. PubMed ID: 2707917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
    Gavazzi A; Mussini A; Bramucci E
    Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.
    Hoit BD; Burwig S; Eppert D; Bhat G; Walsh RA
    Am Heart J; 1994 Dec; 128(6 Pt 1):1156-63. PubMed ID: 7985596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
    Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
    Dei Cas L; Metra M; Nodari S; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S111-7. PubMed ID: 2483436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
    Col J; Mievis E; Reynaert M
    Eur J Clin Pharmacol; 1983; 24(3):297-300. PubMed ID: 6861844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
    De Vita C; Triulzi E; Devizzi S; Colombo G; Palvarini M; Pocchiari F; Pataccini R
    Arzneimittelforschung; 1986 Feb; 36(2A):349-54. PubMed ID: 3707648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.